Leukotech (patent portfolio) Overview
- Latest Deal Type
- Financing Rounds
Leukotech (patent portfolio) General Information
Antibody patent portfolio in Copenhagen, Denmark. The patents relate to antibodies against heparin binding protein (HBP) and biologically active peptides derived from HBP. It addresses the severity of disease development associated with the initial infection and inflammatory processes.
Corporate Backed or Acquired
Buildings and Property
- Symbion Science Park, Fruebjergvej 3
- Box 8
- 2100 Copenhagen
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Leukotech (patent portfolio) Valuation & Funding
Leukotech (patent portfolio) Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|